The average 15.4%-22.9% weight losses across the tirzepatide doses achieved initially in the trial were maintained throughout ...

Dumb Blonde” podcast host Bunnie Xo shared that she’s lost 4 lbs. on the weight-loss drug Tirzepatide and is now “pooping ...

All the evidence gathered from the five-year trial will be used to demonstrate the long-term effect of weight loss medication ...

Novo Nordisk said on Friday its weight-loss drug met the main goals of a late-stage trial in patients with a type of fatty ...

With the FDA approval of the first specific drug for Metabolic Associated Steatohepatitis (MASH) in March this year, Madrigal’s Rezdiffra is a pioneer in a market set for rapid change. | With the FDA ...

The results from a sub-population of patients in Lilly's SURMOUNT-1 trial suggest that tirzepatide could provide an alternative that, at least in theory, could require less dramatic lifestyle changes.

Specifically, the program showed tirzepatide had up to 51.5% effectiveness in managing OSA for trial participants. The results have been submitted to the FDA and EMA for review, with management ...

Tirzepatide is prescribed for type 2 diabetes ... of wraparound care seen in patients who took part in the clinical trial, and which is likely necessary to achieve maximum health benefits.

Analyst Joseph Pantginis of H.C. Wainwright maintained a Buy rating on Palatin Technologies (PTN – Research Report), retaining the price ...

Among other things, the investment will help explore new ways of delivering health services to people living with obesity, and include a five-year trial of the company’s drug tirzepatide ...